Sign Up Today and Learn More About Cresilon, Inc. Stock
Invest in or calculate the value of your shares in Cresilon, Inc. or other pre-IPO companies through EquityZen's platform.
Cresilon, Inc. Stock (CRIN)
Cresilon is a medical device company that produces and markets solutions for trauma care.
About Cresilon, Inc. Stock
Founded
2010
Headquarters
Brooklyn, NY, US
Total Funding
165M
Industries
Science and Engineering, Health Care, Biotechnology
Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL(TM), is a hemostatic gel made from plant-derived materials to stop traumatic bleeding in seconds. It functions as a blood-clotting agent, and also as a scaffold to facilitate skin growth. Cresilon was co-founded by Joe Landolina and Isaac Miller in 2010 and is based in New York, United States.
Cresilon, Inc. Press Mentions
Stay in the know about the latest news on Cresilon, Inc.
Cresilon Receives FDA Clearance for TRAUMAGEL
en • Aug 22, 2024
Cresilon's Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research
prnewswire • Aug 05, 2024
Cresilon Completes First Phase Preclinical Study Of Hemostatic Gel Technology
mpo-mag • Aug 05, 2024
VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services
prnewswire • Jul 03, 2024
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
prnewswire • Jul 03, 2024
Cresilon, Inc. Management
Leadership team at Cresilon, Inc.
CFO, Co-Founder
Isaac Miller
CEO, Co-Founder
Joe Landolina
Join now and verify your accreditation status to gain access to:
- Cresilon, Inc. current valuation
- Cresilon, Inc. stock price
- Available deals in Cresilon, Inc. and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cresilon, Inc. stock?
Accredited investors can buy pre-IPO stock in companies like Cresilon, Inc. through EquityZen funds. These investments are made available by existing Cresilon, Inc. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cresilon, Inc. stock?
Shareholders can sell their Cresilon, Inc. stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
